세계의 수술중 영상 시장 : 시장 규모, 점유율, 동향 분석, 기회, 예측 보고서(2019-2029년)

Intraoperative Imaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Products (Mobile C Arm, Ultrasound, CT ); By Application ; By Region

US $ 4,850 ￦ 6,742,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,750 ￦ 7,994,000

Unprintable PDF (Group License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,330,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. Excel 파일이 제공됩니다.

한글목차

세계의 수술중 영상(Intraoperative Imaging) 시장 규모는 2배 이상 2029년까지 5억 7,750만 달러에 달할 것으로 예상됩니다.

세계의 수술중 영상 시장은 만성 질환의 유병률 증가, 영상 진단 기술의 진보, 저침습 수술에 대한 높은 주목도짐, 수술중 MRI 및 광 간섭 단층계 등의 최신 기술에 의한 혁신 등에 의해 활성화 되고 있습니다.

전략 컨설팅 및 시장 조사의 선두 기업인 BlueWeave Consulting은 최근 조사에서 2022년 세계 수술중 영상 시장 규모를 2억 3,800만 달러로 추정했습니다. 2023년부터 2029년까지의 예측 기간 동안 BlueWeave는 세계 수술중 영상 시장 규모가 CAGR 13.5%로 성장하여 2029년에는 5억 7,747만 달러에 달할 것으로 예측했습니다. 비용 효과적인 의료 솔루션에 대한 수요 증가와 외래 수술 동향도 수술중 영상 수요를 뒷받침하고 있습니다. 수술중 영상 기술은 병원 입원 기간을 단축하고 재수술의 필요성을 최소화함으로써 전반적인 의료 비용을 줄일 수 있습니다. 전반적으로 수술중 영상에 대한 수요 증가는 수술 결과 개선, 환자 안전 개선, 의료비 절감, 의료 종사자 및 환자에게 점점 매력적인 선택이되었습니다. 에 기인합니다. 또한 간질이나 뇌종양 등 신경질환으로 병원에서 치료받는 환자수도 증가하고 있습니다. WHO에 따르면 간질은 세계 5,000만 명 이상의 사람들에게 영향을 미치고 있으며, 세계 질병 부담의 상당 부분을 차지하고 있습니다. 일반 인구에서 차지하는 활동성 간질의 비율은 1,000명당 4-10명으로 추정되고 있습니다. 그러므로 만성질환의 유병률 증가와 기술적으로 고급 영상시스템의 채택은 예측기간 동안 이 부문의 성장을 가속할 것으로 예상됩니다.

상세한 분석은 성장 가능성, 미래 동향, 세계의 수술중 영상 시장 통계에 대한 정보를 제공합니다. 또한 총 시장 규모 예측을 촉진하는 요인도 다루고 있습니다. 세계의 수술중 영상 시장에서 최근 기술 동향을 산업 인사이트와 함께 제공하여 의사 결정자가 적절한 전략적 의사 결정을 할 수 있도록 지원합니다. 또한 시장의 성장 촉진 요인·과제·경쟁력에 대해서도 분석했습니다.

목차

제1장 조사 프레임워크

제2장 주요 요약

제3장 세계의 수술중 영상 시장에 관한 통찰

• 산업의 밸류체인 분석
• DROC 분석
  • 성장의 원동력
    • 수술중 영상 방법에서 기술 진보
    • 의료기기의 연구개발 활동 증가
    • 외과 수술 건수 증가
  • 억제 요인
    • 수술중 영상 시스템의 높은 비용
    • 한정된 숙련된 전문가의 확보
  • 기회
    • 신흥국의 높은 성장 기회
    • 저비용 이미지 시스템 개발
  • 과제
    • 고등학교 예산 증가
    • 대체 영상 기술과의 경쟁
• 기술 진보/최근 개발
• 규제 프레임워크
• Porter's Five Forces 분석

제4장 세계의 수술중 영상 시장 개요

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
    • 모바일 C암
    • 초음파
    • 복강경 프로브
    • 드롭인 프로브
    • 기타 디바이스
    • CT
    • MRI
    • X선
    • 수술중 광학 이미징
  • 용도별
    • 뇌신경외과
    • 정형외과 및 외상외과
    • 척추외과
    • 심장혈관 수술
    • 이비인후과 수술
    • 종양
    • 긴급 및 외상 수술
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아 태평양
    • 남미
    • 중동 및 아프리카

제5장 북미의 수술중 영상 시장

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
  • 용도별
  • 국가별
    • 미국
    • 캐나다

제6장 유럽의 수술중 영상 시장

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
  • 용도별
  • 국가별
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인
    • 벨기에
    • 러시아
    • 네덜란드
    • 기타 유럽

제7장 아시아 태평양의 수술중 영상 시장

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
  • 용도별
  • 국가별
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주 및 뉴질랜드
    • 인도네시아
    • 말레이시아
    • 싱가포르
    • 베트남
    • 기타 아시아 태평양

제8장 남미의 수술중 영상 시장

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
  • 용도별
  • 국가별
    • 브라질
    • 아르헨티나
    • 페루
    • 기타 남미

제9장 중동 및 아프리카 수술중 영상 시장

• 시장 규모 및 금액별 예측(2019-2029년)
  • 금액별
• 시장 점유율 및 예측
  • 제품별
  • 용도별
  • 국가별
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 카타르
    • 쿠웨이트
    • 남아프리카
    • 나이지리아
    • 알제리
    • 기타 중동 및 아프리카

제10장 경쟁 구도

• 주요 기업 및 제품 목록
• 세계의 수술중 영상 기업의 시장 점유율 분석(2021년)
• 운영 파라미터별 경쟁 벤치마킹
• 주요 전략적 개발(합병, 인수, 파트너십 등)

제11장 세계의 수술중 영상 시장에 대한 COVID-19의 영향

제12장 기업 개요(기업 개요, 재무 매트릭스, 경쟁 구도, 주요 인재, 주요 경쟁, 연락처 주소 및 전략적 전망)

• General Electric Company
• Siemens Healthineers AG
• Ziehm Imaging GmbH
• Medtronic
• Koninklijke Philips NV
• Canon Healthcare
• Stryker
• Brainlab AG
• IMRIS
• Shimadzu Corporation
• Shenzhen Anke High-tech Co.
• FUJIFILM Holdings
• Carl Zeiss Meditec AG
• Mindray Ltd
• Carestream Health
• Analogic Corporation
• Allengers Medical Systems Ltd
• Esaote SpA
• Neurologica Corporation
• 기타 기업

제13장 주요 전략적 권장사항

제14장 조사 방법

LYJ

영문 목차

영문목차

Global Intraoperative Imaging Market Size More Than Doubles to Touch worth USD 577.5 Million by 2029

Global intraoperative imaging market is flourishing due to the increasing prevalence of chronic diseases, advancements in imaging technology, a growing focus on minimally invasive surgeries, and innovations driven by modern technologies such as intraoperative MRI and optical coherence tomography.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global intraoperative imaging market size at USD 238.0 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global intraoperative imaging market size to grow at a CAGR of 13.5% reaching a value of USD 577.47 by 2029. The increasing demand for cost-effective healthcare solutions and the growing trend toward outpatient surgeries are also driving the demand for intraoperative imaging. The intraoperative imaging technology can help in reducing the length of hospital stays and minimize the need for repeat surgeries, thereby reducing overall healthcare costs. Overall, the rising demand for intraoperative imaging can be attributed to its ability to improve surgical outcomes, enhance patient safety, and reduce healthcare costs, making it an increasingly attractive option for healthcare providers and patients alike. Furthermore, the number of patients receiving treatment in hospitals for neurological illnesses like epilepsy and brain tumors is on the rise. As per the WHO, epilepsy affects over 50 million individuals globally and accounts for a considerable amount of the global disease burden. The proportion of the general population with active epilepsy is estimated to be between 4 and 10 per 1000 persons. Thus, the increasing prevalence of chronic disorders and the adoption of technically advanced imaging systems are expected to boost this segment's growth during the forecast period.

Opportunity: New Product Development and High Growth Opportunities in Emerging Economies

Developing economies including India, Brazil, South Korea, Turkey, Russia, and South Africa provide significant development potential for intraoperative imaging market participants. Although cost is an issue in these developing countries, their large population bases-particularly in India and China-indicate a long-term market for intraoperative imaging devices. The increased frequency of chronic diseases such as cancer, stroke, nephrology, neurological surgery, and cardiovascular disorders in these countries, as well as the higher death rates, highlight the need of early identification. GLOBOCAN 2018 statistics, for example, suggested that about half of the worldwide cancer population resided in developing nations. Regulatory policies in Asia-Pacific countries are more adaptable and business-friendly than in Western countries. Increased competition in developed countries is projected to push makers of intraoperative imaging systems to focus on emerging markets.

Challenges: Cuts in Healthcare Providers' Budget

In response to increased government pressure to cut healthcare costs, a number of healthcare providers have partnered with group buying organizations (GPOs), integrated health networks (IHNS), and integrated delivery networks (IDNS). These associations pool their members' purchases and negotiate a competitive price with medical equipment suppliers and manufacturers. For mass purchasing of intraoperative imaging devices, GPOs, IHNS, and IDNS bargain hard. The growing cost of prescription medications, combined with a steep decrease in anticipated budget allocations for health and human services in the United States for 2019, have resulted in major cuts to hospital budgets. According to an American Hospital Association analysis, federal hospital payment cuts totaling USD 218 billion by 2028, requiring hospitals to devote less resources yearly.

Segmental Information

Global Intraoperative Imaging Market - By End User:

Based on end user, the global intraoperative imaging market is segmented into hospitals & diagnostic centers, ambulatory surgical centers & clinics, and research laboratories & academic institutes. End users in the intraoperative imaging market were dominated by hospitals and diagnostic centers. Hospitals frequently undertake a wide range of surgical operations, the majority of which are conducted in hospital inpatient settings. The increasing number of minimally invasive operations and electro surgery treatments done in hospitals, as well as the introduction of robotic surgical, are driving growth in this market. Because of their greater purchasing power and higher volume of procedures conducted, hospitals are more likely to use intraoperative imaging equipment. The increased number of orthopedic surgeries conducted in hospitals has resulted from the rising number of vehicle accidents, fall-related injuries, and sports injuries. The increased occurrence of diseases needing surgical treatment promotes the utilization by increasing the procedure volume.

Global Intraoperative Imaging Market - By Region:

Due to the presence of a large number of market players in the region, North America held the highest market share in 2022, and their consistent efforts in developing new products, investing in acquisitions, and R&D activities to support easy operations and ensure the availability of authentic medical-grade imaging systems are expected to drive the market growth. For example, Activ Surgical, a digital surgery pioneer based in the United States, announced FDA clearance of its ActivSight Intraoperative Imaging Module for improved surgical visualization in April 2021. This imaging module provides real-time intraoperative visual data and imaging to surgeons, resulting in improved patient outcomes and operating room safety.

Impact of COVID-19 on the Global Intraoperative Imaging Market

The COVID-19 pandemic had an uneven influence on the intraoperative imaging market. While demand for imaging technologies remains high, the pandemic caused supply chain disruptions, reduced patient volumes, and financial constraints, all of which hampered market growth. Because of the rising number of COVID-19 cases globally, the pandemic spurred the demand for imaging technology in the healthcare business. Intraoperative imaging technologies are being utilized to diagnose and monitor the evolution of COVID-19 patients. Furthermore, as hospitals and healthcare facilities are converted to COVID-19 treatment, the demand for portable and mobile imaging devices has grown.

Competitive Landscape:

Key players in the global intraoperative imaging market include: General Electric Company, Siemens Healthineers AG, Ziehm Imaging GmbH, Medtronic, Koninklijke Philips NV, Canon Healthcare, Stryker, Brainlab AG, IMRIS, Shimadzu Corporation, Shenzhen Anke High-tech Co., FUJIFILM Holdings, Carl Zeiss Meditec AG, Mindray Ltd, Carestream Health, Analogic Corporation, Allengers Medical Systems Ltd, Esaote SpA, and Neurologica Corporation.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Intraoperative Imaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Intraoperative Imaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Intraoperative Imaging Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Technological Advancements in Intraoperative Imaging Modalities
    • 3.2.1.2. Increase in R&D activities in medical devices
    • 3.2.1.3. Increasing number of surgical procedures
  • 3.2.2. Restraints
    • 3.2.2.1. High Cost of Intraoperative imaging systems
    • 3.2.2.2. Limited availability of skilled professionals
  • 3.2.3. Opportunity
    • 3.2.3.1. High Growth Opportunities in Emerging Countries
    • 3.2.3.2. Development of low-cost imaging systems
  • 3.2.4. Challenges
    • 3.2.4.1. Higher Budgets of High School
    • 3.2.4.2. Competition from alternative imaging technologies
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Intraoperative Imaging Market Overview

• 4.1. Market Size & Forecast by Value, 2019-2029
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Mobile C Arm
    • 4.2.1.2. Ultrasound
    • 4.2.1.2.1. Laparoscopic probes
    • 4.2.1.2.2. Drop-in-probes
    • 4.2.1.2.3. Other devices
    • 4.2.1.3. CT
    • 4.2.1.4. MRI
    • 4.2.1.5. X rays
    • 4.2.1.6. Intraoperative Optical Imaging
  • 4.2.2. By Application
    • 4.2.2.1. Neurosurgery
    • 4.2.2.2. Orthopaedic & Trauma Surgery
    • 4.2.2.3. Spine Surgery
    • 4.2.2.4. Cardiovascular Surgery
    • 4.2.2.5. ENT Surgery
    • 4.2.2.6. Oncology
    • 4.2.2.7. Emergency & Trauma Surgery
    • 4.2.2.8. Others
  • 4.2.3. By Region
    • 4.2.3.1. North America
    • 4.2.3.2. Europe
    • 4.2.3.3. Asia Pacific
    • 4.2.3.4. Latin America
    • 4.2.3.5. Middle East and Africa

5. North America Intraoperative Imaging Market

• 5.1. Market Size & Forecast by Value, 2019-2029
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Application
  • 5.2.3. By Country
    • 5.2.3.1. United States
    • 5.2.3.1.1. By Product
    • 5.2.3.1.2. By Application
    • 5.2.3.2. Canada
    • 5.2.3.2.1. By Product
    • 5.2.3.2.2. By Application

6. Europe Intraoperative Imaging Market

• 6.1. Market Size & Forecast by Value, 2019-2029
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
    • 6.2.3.1. Germany
    • 6.2.3.1.1. By Product
    • 6.2.3.1.2. By Application
    • 6.2.3.2. United Kingdom
    • 6.2.3.2.1. By Product
    • 6.2.3.2.2. By Application
    • 6.2.3.3. Italy
    • 6.2.3.3.1. By Product
    • 6.2.3.3.2. By Application
    • 6.2.3.4. France
    • 6.2.3.4.1. By Product
    • 6.2.3.4.2. By Application
    • 6.2.3.5. Spain
    • 6.2.3.5.1. By Product
    • 6.2.3.5.2. By Application
    • 6.2.3.6. Belgium
    • 6.2.3.6.1. By Product
    • 6.2.3.6.2. By Application
    • 6.2.3.7. Russia
    • 6.2.3.7.1. By Product
    • 6.2.3.7.2. By Application
    • 6.2.3.8. The Netherlands
    • 6.2.3.8.1. By Product
    • 6.2.3.8.2. By Application
    • 6.2.3.9. Rest of Europe
    • 6.2.3.9.1. By Product
    • 6.2.3.9.2. By Application

7. Asia-Pacific Intraoperative Imaging Market

• 7.1. Market Size & Forecast by Value, 2019-2029
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
    • 7.2.3.1. China
    • 7.2.3.1.1. By Product
    • 7.2.3.1.2. By Application
    • 7.2.3.2. India
    • 7.2.3.2.1. By Product
    • 7.2.3.2.2. By Application
    • 7.2.3.3. Japan
    • 7.2.3.3.1. By Product
    • 7.2.3.3.2. By Application
    • 7.2.3.4. South Korea
    • 7.2.3.4.1. By Product
    • 7.2.3.4.2. By Application
    • 7.2.3.5. Australia & New Zealand
    • 7.2.3.5.1. By Product
    • 7.2.3.5.2. By Application
    • 7.2.3.6. Indonesia
    • 7.2.3.6.1. By Product
    • 7.2.3.6.2. By Application
    • 7.2.3.7. Malaysia
    • 7.2.3.7.1. By Product
    • 7.2.3.7.2. By Application
    • 7.2.3.8. Singapore
    • 7.2.3.8.1. By Product
    • 7.2.3.8.2. By Application
    • 7.2.3.9. Vietnam
    • 7.2.3.9.1. By Product
    • 7.2.3.9.2. By Application
    • 7.2.3.10. Rest of APAC
    • 7.2.3.10.1. By Product
    • 7.2.3.10.2. By Application

8. Latin America Intraoperative Imaging Market

• 8.1. Market Size & Forecast by Value, 2019-2029
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
    • 8.2.3.1. Brazil
    • 8.2.3.1.1. By Product
    • 8.2.3.1.2. By Application
    • 8.2.3.2. Argentina
    • 8.2.3.2.1. By Product
    • 8.2.3.2.2. By Application
    • 8.2.3.3. Peru
    • 8.2.3.3.1. By Product
    • 8.2.3.3.2. By Application
    • 8.2.3.4. Rest of LATAM
    • 8.2.3.4.1. By Product
    • 8.2.3.4.2. By Application

9. Middle East & Africa Intraoperative Imaging Market

• 9.1. Market Size & Forecast by Value, 2019-2029
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
    • 9.2.3.1. Saudi Arabia
    • 9.2.3.1.1. By Product
    • 9.2.3.1.2. By Application
    • 9.2.3.2. UAE
    • 9.2.3.2.1. By Product
    • 9.2.3.2.2. By Application
    • 9.2.3.3. Qatar
    • 9.2.3.3.1. By Product
    • 9.2.3.3.2. By Application
    • 9.2.3.4. Kuwait
    • 9.2.3.4.1. By Product
    • 9.2.3.4.2. By Application
    • 9.2.3.5. South Africa
    • 9.2.3.5.1. By Product
    • 9.2.3.5.2. By Application
    • 9.2.3.6. Nigeria
    • 9.2.3.6.1. By Product
    • 9.2.3.6.2. By Application
    • 9.2.3.7. Algeria
    • 9.2.3.7.1. By Product
    • 9.2.3.7.2. By Application
    • 9.2.3.8. Rest of MEA
    • 9.2.3.8.1. By Product
    • 9.2.3.8.2. By Application

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Intraoperative Imaging Company Market Share Analysis, 2021
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Intraoperative Imaging Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

• 12.1. General Electric Company
• 12.2. Siemens Healthineers AG
• 12.3. Ziehm Imaging GmbH
• 12.4. Medtronic
• 12.5. Koninklijke Philips NV
• 12.6. Canon Healthcare
• 12.7. Stryker
• 12.8. Brainlab AG
• 12.9. IMRIS
• 12.10. Shimadzu Corporation
• 12.11. Shenzhen Anke High-tech Co.
• 12.12. FUJIFILM Holdings
• 12.13. Carl Zeiss Meditec AG
• 12.14. Mindray Ltd
• 12.15. Carestream Health
• 12.16. Analogic Corporation
• 12.17. Allengers Medical Systems Ltd
• 12.18. Esaote SpA
• 12.19. Neurologica Corporation
• 12.20. Other Prominent Companies

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumption & Limitation

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

관련자료